Xenotransplantation

British Journal of Surgery

Volumn 86, Issue 12, 1999, Pages 1499-1514

  White, S A ^a   Nicholson, M L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COMPLEMENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROSTAGLANDIN E1; RAPAMYCIN; TACROLIMUS;

ANIMAL TISSUE; BIOTECHNOLOGY; DRUG TOXICITY; GOAT; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOMODULATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MEDICAL ETHICS; MEDICAL INFORMATION; MOLECULAR BIOLOGY; NATURAL KILLER CELL; NONHUMAN; ORGAN DONOR; PANCREAS TRANSPLANTATION; PRIMATE; PRIORITY JOURNAL; RABBIT; RETROVIRUS INFECTION; REVIEW; SHEEP; SWINE; XENOTRANSPLANTATION; ZOONOSIS;

EID: 0032787157     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1999.01340.x     Document Type: Review

References (178)

1. 1 United Kingdom Transplant Support Services Association. Transplant Statistics 1998.
2. 2 Williams PW. Notes on diabetes treated with extract and by grafts of sheep's pancreas. BMJ 1894; ii: 1303-4.
3. 3 Reemtsma K, Benvenisty AI. Experience with clinical kidney xenotransplantation. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, eds. Xenotransplantation. The Transplantation of Organs and Tissues Between Species. Berlin: Springer, 1991: 531-40.
4. 4 Princeteau M. Greffe renale. J Med Bordeaux 1905; 26: 549.
5. 5 Jaboulay M. Greffe de reins au pli du coude par soudres arterielles et veineuses. Lyon Medicale 1906; 39: 575-7.
6. 6 Unger I. Transplantation des vaisseaux et des organes. B Fur Chir 1908; 46: 1367-70.
7. 7 Neuhof H. The Transplantation of Tissues. New York: Appleton, 1923.
8. 8 Reemtsma K, McCracken BH, Schlegel JU, Pearl MA, Pearce CW, DeWitt CW et al. Renal heterotransplantation in man. Ann Surg 1964; 160: 384-408.
9. 9 Hitchcock CR, Kiser JC, Telander RL, Seljeskog EL. Baboon renal grafts. JAMA 1964; 189: 934-7.
10. 10 Starzl TE, Marchioro TL, Peters GN, Kirkpatrick CH, Wilson WEC, Porter KA et al. Renal heterotransplantation from baboon to man: experience with six cases. Transplantation 1964; 2: 752-76.
11. 11 Hume DM. Discussion of Reemtsma paper. Ann Surg 1964; 160: 409-10.
12. 12 Hardy JD, Chavez CM, Kurrus FD, Neely WA, Eraslan S, Turner MD et al. Heart transplantation in man: developmental studies and a report of a case. JAMA 1964; 188: 1132-40.
13. 13 Traeger J, Fries D, Perrin J. Heterotransplantation chez l'homme. Premiers resultats. Proceedings of the European Dialysis and Transplant Association 1965; 2: 214-17.
14. 14 Council on Scientific Affairs. Xenografts: review of the literature and current status. JAMA 1985; 254: 3353-7.
15. 15 Cooley DA, Hallman GL, Bloodwell RD, Nora JJ, Leachman RD. Human heart transplantation. Experience with twelve cases. Am J Cardiol 1968; 22: 804-10.
16. 16 Cortesini R, Casciani C, Cucchiara G. Heterotransplantation in primates: current state of affairs. In: Balner H, ed. Infection and Immunosuppression in Subhuman Primates. Copenhagen: Munksgaard, 1969: 239-48.
17. 17 Ross DN. Experience with human heart transplantation. In: Shapiro HA, ed. Proceedings of the Cape Town Symposium 13-16 July 1968. Durban: Butterworths, 1969: 111-46.
18. 18 Marion P. Les transplantations cardiaques et les transplantations hepatiques. Lyon Med 1969; 222: 585-607.
19. 19 Starzl TE. Baboon renal and chimpanzee liver heterotransplantation. In: Hardy MA, ed. Xenograft 25. Amsterdam: Excerpta Medica, 1989: 17-28.
20. 20 Barnard CN, Wolpowitz A, Losman JG. Heterotopic cardiac transplantation with a xenograft for assistance of the left heart in cardiogenic shock after cardiopulmonary bypass. S Afr Med J 1977; 52: 1035-8.
21. 21 Bailey LL, Nehlsen-Cannarella SL, Concepcion W, Jolley WB. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985; 254: 3321-9.
22. 22 Starzl TE, Fung J, Tzakis A, Todo S, Demetris AJ, Marino IR et al. Baboon-to-human liver transplantation. Lancet 1993; 341: 65-71.
23. 23 Makowka L, Cramer DV, Hoffman A, Breda M, Sher L, Eiras-Hreha G et al. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 1995; 59: 1654-9.
24. 24 Czaplicki T, Blonska B, Religa Z. The lack of hyperacute xenogeneic heart transplant rejection in a human. J Heart Lung Transplant 1992; 11: 393-7 (Letter).
25. 25 Groth CG, Korsgren O, Tibell A, Tollemar J, Moller E, Bolinder J et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994; 344: 1402-4.
26. 26 Eiseman B, Liem DS, Raffucci F. Heterologous liver perfusion in treatment of hepatic failure. Ann Surg 1965; 162: 329-45.
27. 27 Hering BJ. International Islet Transplant Registry Report. ITR 1995; 5: 2-27.
28. 28 Korsgren O, Groth CG, Andersson A, Hellerstrom C, Tibell A, Tollemar J et al. Transplantation of porcine fetal pancreas to a diabetic patient. Transplant Proc 1992; 24: 352-3.
29. 29 Andersson A, Groth CG, Korsgren O, Tibell A, Tollemar J, Kumagai M et al. Transplantation of porcine fetal islet-like cell clusters to three diabetic patients. Transplant Proc 1992; 24: 677-8.
30. 30 Groth CG, Andersson A, Korsgren O, Tibell A, Tollemar J, Kumagai M et al. Transplantation of porcine fetal islet-like cell clusters into eight diabetic patients. Transplant Proc 1993; 25: 970.
31. 31 Tibell A, Groth CG, Möller E, Korsgren O, Andersson A, Hellerström C. Pig-to-human islet transplantation in eight patients. Transplant Proc 1994; 26: 762-3.
32. 32 Deacon T, Schumacher J, Dinsmore J, Thomas C, Palmer P, Kott S et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 1997; 3: 350-2.
33. 33 Hammer C. Evolutionary, physiological, and immunological considerations in defining a suitable donor for man. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, eds. Xenotransplantation. The Transplantation of Organs and Tissues Between Species. Berlin: Springer, 1991: 429-38.
34. 34 Balner H. Choice of animal species for modern transplant research. Transplant Proc 1974; 6(4 Suppl 1): 19-25.
35. 35 Caplan AL. Is xenografting morally wrong? Transplant Proc 1992; 24: 722-7.
36. 36 Niekrasz M, Ye Y, Rolf LL, Zuhdi N, Cooper DKC. The pig as organ donor for man. Transplant Proc 1992; 24: 625-6.
37. 37 Hammer C, Linke R, Wagner F, Diefenbeck M. Organs from animals for man. Int Arch Allergy Immunol 1998; 116: 5-21.
38. 38 Hammer C. Physiological obstacles in xenotransplantation. Ann NY Acad Sci 1998; 862: 19-27.
39. 39 Perper RJ, Najarian JS. Experimental renal heterotransplantation; I. In widely divergent species. Transplantation 1966; 4: 377-88.
40. 40 Calne RY. Organ transplantation between widely disparate species. Transplant Proc 1970; 2: 550-6.
41. 41 Auchincloss H Jr, Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433-70.
42. 42 Luzi L, Battezzati A, Perseghin G, Bianchi E, Terruzzi I, Spotti D et al. Combined pancreas and kidney transplantation normalizes protein metabolism in insulin-dependent diabetic uremic patients. J Clin Invest 1994; 93: 1948-58.
43. 43 Eckstein V, Ulrichs K, Meincke G, Müller Ruchholtz W. Natural xenophile antibodies from sera of type 1 diabetic patients differ strongly in their reactivity against various porcine pancreatic cells. Transplant Proc 1992; 24: 681-3.
44. 44 Schaapherder AFM, Daha MR, van der Woude FJ, Bruijn JA, Gooszen HG. IgM, IgG and IgA and antibodies in human sera directed against porcine islets of Langerhans. Transplantation 1993; 56: 1576-9.
45. 45 Oriol R, Ye Y, Koren E, Cooper DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433-12.
46. 46 Ulrichs K, Eckstein V, Korsgren O, Tibell A, Groth CG, Muller Ruchholtz W. Characterization of natural and induced human xenophile antibodies before and after transplantation of the fetal porcine endocrine pancreas. Transplant Proc 1994; 26: 1391.
47. 47 Kunori T, Mimori M, Yamauchi I. How many human B-cells are spontaneously producing antibodies against animal cells? Transplant Proc 1992; 24: 448.
48. 48 Turman MA, Casali P, Notkins AL, Bach FH, Platt JL. Polyreactivity and antigen specificity of human xenoreactive monoclonal and serum natural antibodies. Transplantation 1991; 52: 710-17.
49. 49 Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52: 214-20.
50. 2. Transplantation 1993; 55: 1144-50.
51. 51 Hammarstrom L, Smith CIE. IgG subclasses in bacterial infections. Monogr Allergy 1986; 19: 122-33.
52. 52 Hammer C, Hingerle M. Development of preformed natural antibodies in gnotobiotic dogs and pigs, impact of food antigens on antibody specificity. Transplant Proc 1992; 24: 707-9.
53. 53 Hammer C, Höbel G, Csapo C. Fixation of mammalian natural antibodies to porcine endothelial cells. Transplant Proc 1992; 24: 588-9.
54. 54 Markmann JF, Barker CF. Basic and clinical considerations in the use of xenografts. Curr Probl Surg 1994; 31: 396-460.
55. 55 Geller RL, Bach FH, Turman MA, Casali P, Platt JL. Evidence that polyreactive antibodies are deposited in rejected discordant xenografts. Transplantation 1993; 55: 168-72.
56. 56 Ratner AJ, Canhui H, Pepino P, Sanchez JA, Edwards N, Watkins JF et al. Lymphocyte xenoantigens recognized by pre-formed antibodies. Transplant Proc 1992; 24: 583-5.
57. 57 Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991; 52: 937-47.
58. 58 Platt JL, Holzknecht ZE, Lindman BJ. Porcine endothelial cell antigens recognized by human natural antibodies. Transplant Proc 1994; 26: 1387.
59. 59 Galili U, Rachmilewitz EA, Peleg A, Flechner I. A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med 1984; 160: 1519-31.
60. 60 Galili U. Interaction of the natural anti-Gal antibody with galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14: 480-2.
61. 61 McKenzie IFC, Koulmanda M, Mandel TE, Xing P-X, Sandrin MS. Pig to human xenotransplantation: the expression of gal α(1-3)Gal eptitopes on pig islet cells. Xenotransplantation 1995; 2: 1-7.
62. 62 Galili U, Tibell A, Samuelsson B, Rydberg L, Groth CG. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation 1995; 59: 1549-56.
63. 63 Koulmanda M, McKenzie IFC, Sandrin MS, Mandel TE. Fetal pig islet xenografts in NOD-Lt mice; the effect of peritransplant anti-CD4 monoclonal antibody and graft immunomodification on graft survival, and lack of expression of Gal(α1-3) Gal on endocrine cells. Xenotransplantation 1995; 2: 295-305.
64. 64 Candinas D, Belliveau S, Koyamada N, Miyatake T, Hechenleitner P, Mark W et al. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. Transplantation 1996; 62: 1920-7.
65. 65 Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC. Delayed xenograft rejection. Immunol Today 1996; 17: 379-84.
66. 66 Hancock WW. Delayed xenograft rejection. World J Surg 1997; 21: 917-23.
67. 67 Murase N, Starzl TE, Demetris AJ, Valdevia L, Tanabe M, Cramer D et al. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 1993; 55: 701-8.
68. 68 Lin Y, Vandeputte M, Waer M. Contribution of activated macrophages to the process of delayed xenograft rejection. Transplantation 1997; 64: 1677-83.
69. 69 Inveradi L, Samaji M, Motterlini R, Mangili F, Bender JR, Pardi R. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol 1992; 149: 1416-23.
70. 70 Torgersen KM, Salcedo M, Vaage JT, Naper C, Rolstad B, Ljunggren HG et al. Major histocompatibility complex class I-independent killing of xenogeneic targets by rat allospecific natural killer cells. Transplantation 1997; 63: 119-23.
71. 71 Gourlay WA, Chambers WH, Monaco AP, Maki T. Importance of natural killer cells in the rejection of hamster skin xenografts. Transplantation 1998; 65: 727-34.
72. 72 Inveradi L, Clissi B, Stolzer AL, Bender JR, Sandrin MS, Pardi R. Human natural killer lymphocytes directly recognize evolutionary conserved oligosaccharide ligands expressed by xenogeneic tissues. Transplantation 1997; 63: 1318-30.
73. 73 Karre K. Express yourself or die: peptides, MHC molecules, and NK cells. Science 1995; 267: 978-9.
74. 74 Johnston PS, Wang MW, Lim SML, Wright LJ, White DJG. Discordant xenograft rejection in an antibody-free model. Transplantation 1992; 54: 573-6.
75. 75 Reid KBM. Proteins involved in the activation and control of the two pathways of human complement. Biochem Soc Trans 1983; 11: 1-12.
76. 2+ on the lytic process. J Immunol 1987; 138: 1530-6.
77. 77 Baldwin WM III, Pruitt SK, Brauer RB, Daha MR, Sanfilippo F. Complement in organ transplantation. Contributions to inflammation, injury, and rejection. Transplantation 1995; 59: 797-808.
78. 78 Kirk AD, Heinle JS, Mault JR, Sanfilippo FP. Ex vivo characterization of human anti-porcine hyperacute cardiac rejection. Transplantation 1993; 56: 785-93.
79. 79 Makowka L, Wu GD, Hoffman A, Podesta L, Sher L, Tuso PJ et al. Immunohistopathologic lesions associated with the rejection of a pig-to-human liver xenograft. Transplant Proc 1994; 26: 1074-5.
80. 80 Dalmasso AP, Platt JL. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor. Transplantation 1993; 56: 1171-6.
81. 81 Tuso PJ, Cramer DV, Yasunaga C, Cosenza CA, Wu GD, Makowka L. Removal of natural human xenoantibodies to vascular endothelium by perfusion of blood through pig kidneys and livers. Transplantation 1993; 55: 1375-8.
82. 82 Gewurz H, Clark H, Cooper MD, Varco RL, Good RA. Effect of cobra venom-induced inhibition of complement activity on allograft and xenograft rejection reactions. Transplantation 1967; 5: 1296-303.
83. 83 Dalmasso AP, Vercellotti GM, Platt JL, Bach FH. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor: potential for prevention of xenograft hyperacute rejection. Transplantation 1991; 32: 530-3.
84. 84 Platt JL, Bach FH. Mechanism of tissue injury in hyperacute xenograft rejection. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, eds. Xenotransplantation. The Transplantation of Organs and Tissues Between Species. Berlin: Springer, 1991: 69-79.
85. 85 Heemann UW, Tullius SG, Azuma H, Kupiec-Weglinsky J, Tilney NL. Adhesion molecules and transplantation. Ann Surg 1994; 219: 4-12.
86. 86 Bach FH. Xenotransplantation: problems for consideration. Clin Transplant 1991; 5: 595-9.
87. 87 Dunning J, Braidley PC, Wallwork J, White DJG. Analysis of hyperacute rejection of pig hearts by human blood using an ex vivo perfusion model. Transplant Proc 1994; 26: 1016-17.
88. 88 Baldamus CA, McKenzie IFC, Winn HJ, Russell PS. Acute destruction by humoral antibody of rat skin grafted to mice. J Immunol 1973; 110: 1532-41.
89. 89 Menger MD, Jäger S, Walter P, Feifel G, Hammersen F, Messmer K. Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes 1989; 38(Suppl 1): 199-201.
90. 90 Andersson A, Korsgren O, Jansson L. Intraportally transplanted pancreatic islets revascularized from hepatic arterial system. Diabetes 1989; 38(Suppl 1): 192-5.
91. 91 Auchincloss H Jr. Xenogeneic transplantation. A review. Transplantation 1988; 46: 1-20.
92. 92 Deng S, Bühler L, Lou J, Grant G, Redard M, Bubloz C et al. Study of concordant xenografted islets of Langerhans rejection: humoral or cellular mechanism? Transplant Proc 1994; 26: 1184-5.
93. 93 Gill RG. Pancreatic islet xenotransplantation. Autoimmunity 1993; 15(Suppl): 18-20.
94. 94 Woolnough JA, Misko IS, Lafferty KJ. Cytotoxic and proliferative lymphocyte responses to allogeneic and xenogeneic antigens in vitro. Australian Journal of Experimental Biology and Medical Science 1979; 57: 467-77.
95. 95 Moses RD, Auchincloss H Jr. Mechanisms of cellular xenograft rejection. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, eds. Xenotransplantation. The Transplantation of Organs and Tissues Between Species. Berlin: Springer, 1991: 101-20.
96. 96 Engelhard VH, Le AXT, Holterman MJ. Species-specific structural differences in the alpha 1 + alpha 2 domains determine the frequency of murine cytotoxic T cell precursors stimulated by human and murine class 1 molecules. J Immunol 1988; 141: 1835-9.
97. 97 Dorling A, Riesbeck K, Lechler RI. The T cell response to xenografts. Xeno 1996; 4: 68.
98. 98 Irwin MJ, Heath WR, Sherman LA. Species-restricted interactions between CD8 and the alpha 3 domain of class I influence in magnitude of the xenogeneic response. J Exp Med 1989; 170: 1091-101.
99. 99 Haisch CE, Lodge PA, Huber SA, Thomas FT. Vascular endothelial cell is central to xenogeneic immune reactivity. Surgery 1990; 108: 306-11.
100. 100 Yamada K, Sachs D, DerSimonian H. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 1995; 155: 5249-56.
101. 101 Moses RD, Pierson RN III, Winn HJ, Auchincloss H Jr. Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse. J Exp Med 1990; 172: 567-75.
102. 102 Gill RG. The role of direct and indirect antigen presentation in the response to islet xenografts. Transplant Proc 1992; 24: 642-3.
103. 103 Dorling A, Binns R, Lechler R. Cellular xenoresponses: observation of significant primary indirect human T cell anti-pig xenoresponses using co-stimulator-deficient or SLA class II negative porcine stimulators. Xenotransplantation 1996; 3: 112-19.
104. 104 Gotoh M, Porter J, Monaco AP, Maki T. Prolongation of islet xenograft survival by islet irradiation and antilymphocyte serum treatment of recipents. Transplant Proc 1988; 20(Suppl 1): 997-9.
105. 105 Gill RG, Coulombe M. Rejection of pancreatic islet xenografts does not require CD8+ T-lymphocytes. Transplant Proc 1992; 24: 2877-8.
106. 106 Lacy PE. Status of islet cell transplantation. Diabetes Reviews 1993; 1: 76-92.
107. 107 Chitilian HV, Laufer TM, Stenger KS, Shea S, Auchincloss H Jr. The strength of cell-mediated xenograft rejection in the mouse is due to the CD4+ indirect response. Xenotransplantation 1998; 5: 93-8.
108. 108 Dorling A, Lechler RI. T cell-mediated xenograft rejection: specific tolerance is probably required for long-term xenograft survival. Xenotransplantation 1998; 5: 234-45.
109. + helper T cells and self antigen-presenting cells in the mouse. J Exp Med 1990; 172: 567-75.
110. 110 Wallgren AC, Karlsson-Parra A, Korsgren O. The main infiltrating cell in xenograft rejection is a CD4+ macrophage and not a T lymphocyte. Transplantation 1995; 60: 594-601.
111. + T-lymphocyte-deficient recipients. Transplant Proc 1993; 25: 961-2.
112. 112 Greenstein JL, Foran JA, Gorga JC, Burakoff SJ. The role of T cell accessory molecules in the generation of class II-specific xenogeneic cytolytic T cells. J Immunol 1986; 136: 2358-63.
113. 113 The US Multicenter FK506 Liver Study Group. A comparison of Tacrolimus (FK506) and Cyclosporin for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110-15.
114. 114 European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423-8.
115. 115 Tze WJ, Tai J, Cheung SSC, Bissada N, Starzl TE. Prolongation of pig islet xenograft survival in rats by local immunosuppression with FK506. Transplant Proc 1994; 26: 777-8.
116. 116 Borg AJ, Kumagai M. FK 506 and xenogeneic human anti-porcine cellular reactivity. Transplant Proc 1991; 23: 2972-3.
117. 117 Eugui EM, Almquist SJ, Muller CD, Allison AC. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol 1991; 33: 161-73.
118. 118 Figueroa J, Fuad SA, Kunjummen BD, Platt JL, Bach FH. Suppression of synthesis of natural antibodies by mycophenolate mofetil (RS-61443). Its potential use in discordant xenografting. Transplantation 1993; 55: 1371-4.
119. 119 Tze WJ, Tai J, Cheung S. In vitro effects of FK-506 on human and rat islets. Transplantation 1990; 49: 1172-4.
120. 120 Knechtle SJ, Halperin EC, Bollinger RR. The effect of TLI and cyclosporin on xenograft survival. Transplantation 1990; 50: 1082-3.
121. 121 Nakajima Y, Yabuuchi H, Kanehiro H, Wada T, Hisanaga M, Nakano H. Prolongation of pancreatic islet xenograft survival and thymus alteration by 15-deoxyspergualin. Transplantation 1989; 48: 351-2.
122. 122 Tepper MA, Petty B, Bursuker I, Pasternak RD, Cleaveland J, Spitainy GL et al. Inhibition of antibody production by immunosuppressive agent, 15-deoxyspergualin. Transplant Proc 1991; 23: 328-31.
123. 123 Nakajima Y, Yoshimura A, Kanehiro H, Aomatsu Y, Nakano H. Mode of action of 15-deoxyspergualin in xenografting islets of Langerhans. Transplant Proc 1994; 26: 1093-4.
124. 124 Hisanaga M, Nakajima Y, Yabuuchi H, Nakano H. Successful combination therapy with FK 506 and 15-deoxyspergualin in pancreatic islet xenografting. Transplant Proc 1992; 24: 1043-4.
125. 125 Leventhal J, Flores HC, Gruber SA, Figueroa J, Platt JL, Manivel JC et al. Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. Transplantation 1992; 54: 26-31.
126. 126 Henretta J, Pittman K, McFadden T, Thomas J, Thomas F. Deoxyspergualin and rabbit antithymocyte globulin markedly prolong discordant pig pancreatic islet xenografts. Transplant Proc 1993; 25: 412-13.
127. 127 Siemasko KF, Chong ASF, Williams JW, Bremer EG, Finnegan A. Regulation of B cell function by the immunosuppressive agent leflunomide. Transplantation 1996; 61: 635-42.
128. 128 Lin Y, Sobis H, Vandeputte M, Waer M. Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine. Transplant Proc 1994; 26: 3202.
129. 129 Lin Y, Vandeputte M, Waer M. Surpression of T-independent IgM xenoantibody formation by leflunomide during xenografting of hamster hearts in rats. Transplantation 1998; 65: 332-9.
130. 130 Molnar-Kimber KL. Mechanism of action of rapamycin (Sirolimus, Rapamune®). Transplant Proc 1996; 28: 964-9.
131. 131 Alexandre GPJ, Gianello P, Latinne D, Carlier M, Dewaele A, Van Obbergh L et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation. In: Hardy MA, ed. Xenograft 25. Amsterdam: Elsevier Science, 1989: 259-66.
132. 132 Euhler NH, Krey U, Schroder O, Loffler H. Membrane plasmapheresis technique in rats. Confirmation of antibody rebound. J Immunol Methods 1985; 84: 313-19.
133. 133 Van de Stadt J, Vendeville B, Weill B, Crougneau S, Michel A, Filipponi F et al. Discordant heart xenografts in the rat. Additional effect of plasma exchange and cyclosporin, cyclophosphamide, or splenectomy in delaying hyperacute rejection. Transplantation 1988; 45: 514-18.
134. 134 Shapiro R, Tzakis AG, Scantlebury V, Makowka L, Watt R, Oks A et al. Immunodepletion in xenotransplantation. J Invest Surg 1990; 3: 39-49.
135. 135 Fischel RJ, Platt JL, Matas AJ, Perry E, Daknassi AP, Manivel C et al. Prolonged survival of a discordant cardiac xenograft in a rhesus monkey. Transplant Proc 1991; 23: 589-90.
136. 136 Palmer A, Taube D, Welsh K, Gjorstrup P, Bewick M, Thick M. Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation. Lancet 1989; i: 10-12.
137. 137 Bach FH, Platt JL, Cooper DKC. Accommodation - the role of natural antibody and complement in discordant xenograft rejection. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, eds. Xenotransplantation. The Transplantation of Organs and Tissues Between Species. Berlin: Springer, 1991: 81-99.
138. 138 Otte KE, Steinbrüchel D, Kain H, Kemp E. Xenoperfusion experiments are suitable for xenotransplantation research. Transplant Proc 1992; 24: 449-50.
139. 139 Rossi M, Dellagiacoma G, Marrazzo T, Tessitore N, Radin S. Xenotransplantation of UV-B irradiated islets. Transplant Proc 1992; 24: 656-7.
140. 140 Chabot J, Weber C, Hardy MA, Rivera S, Baily Braxton D, Strausberg L et al. Synergy of ALS and UV-B in prolongation of primate-to-mouse islet xenograft survival. Transplant Proc 1987; 19: 1160-5.
141. 141 O'Shea GM, Sun AM. Encapsulation of rat islets of Langerhans prolongs xenograft survival in diabetic mice. Diabetes 1986; 35: 943-6.
142. 142 Weber CJ, Zabinsi S, Koschitzky T, Rajotte R, Wicker L, Peterson L et al. Microencapsulated dog and rat islet xenografts into streptozotocin-diabetic and NOD mice. Horm Metab Res Suppl 1990; 25: 219-26.
143. 143 Zhou D, Sun YL, Vacek I, Ma P, Sun AM. Normalization of diabetes in cynomologous monkeys by xenotransplantation of microencapsulated porcine islets. Transplant Proc 1994; 26: 1091.
144. 144 Sun YL, Ma X, Zhou D, Vacek I, Sun AM. Porcine pancreatic islets: isolation, microencapsulation, and xenotransplantation. Artif Organs 1993; 17: 727-33.
145. 145 Lanza RP, Kühtreiber WM, Ecker D, Staruk JE, Chick WL. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation 1995; 59: 1377-84.
146. 146 Weber CJ, Zabinski S, Koschitzky T, Wicker L, Rajotte R, D'Agati V et al. The role of CD4+ helper T cells in the destruction of microencapsulated islet xenografts in nod mice. Transplantation 1990; 49: 396-404.
147. 147 White DJG, Oglesby T, Liszewski MK, Tedja I, Hourcade D, Wang MW et al. Expression of human decay accelerating factor on mouse cells inhibits lysis by human complement. Transplant Proc 1992; 24: 474-6.
148. 148 Langford GA, Yannoutsos N, Cozzi E, Lancaster R, Elsome K, Chen P et al. Production of pigs transgenic for human decay accelerating factor. Transplant Proc 1994; 26: 1400-1.
149. 149 White DJG, Braidley P, Dunning J, Cozzi E, Chavez G, Langford G et al. Hearts from pigs transgenic for human DAF are not hyperacutely rejected when xenografted to primates. Third International Congress for Xenotransplantation. Boston, Massachusetts, September 1995.
150. 150 Waterworth PD, Cozzi E, Tolan MJ, Langford G, Braidley P, Chavez G et al. Pig-to-primate cardiac xenotransplantation and cyclophosphamide therapy. Transplant Proc 1997; 29: 899-900.
151. 151 Dabkowski PL, Vaughan HA, McKenzie IFC, Sandrin MS. Isolation of a cDNA clone encoding the pig α 1,3,galactosyltransferase. Transplant Proc 1994; 26: 1335.
152. 152 Cohney S, McKenzie IFC, Patton K, Prenzoska J, Ostenreid K, Fodor WL et al. Down-regulation of Gal α(1,3)Gal expression by α1,2-fucosyltransferase - further characterization of α1,2-fucosyltransferase transgenic mice. Transplantation 1997; 64: 495-500.
153. 153 Sandrin MS, Fodor WL, Mouhtouris E, Osman N, Cohney S, Rollins SA et al. Enzymatic remodelling of the carbohydrate surface of xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995; 1: 1261-7.
154. 154 Chen C-G, Salvaris EJ, Romanella M, Aminian A, Katerelos M, Fisicaro N et al. Transgenic expression of human α 1,2-fucosyltransferase (H-Transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection. Transplantation 1998; 65: 832-7.
155. 155 Sandrin MS, Foder WL, Cohney S, Mouhtouris E, Osman N, Rollins SA et al. Reduction of the major porcine xenoantigen Gal α (1,3) Gal expression of α (1,2) fucosyltransferase. Xenotransplantation 1996; 3: 134-40.
156. 156 Dabkowski PL, Vaughan HA, McKenzie IFC, Sandrin MS. Characterisation of a cDNA clone encoding the pig α 1,3 galactosyltransferase: implications for xenotransplantation. Transplant Proc 1993; 25: 2921.
157. 157 Billingham RE, Brent L, Medawar PB. 'Actively acquired tolerance' of foreign cells. Nature 1953; 172: 603-6.
158. 158 Douglas JD. Suitability and availability of chimpanzees as organ donors for man. Transplant Proc 1970; 2: 539-41.
159. 159 Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168-70.
160. 160 Li H, Ricordi C, Demetris AJ, Kaufman CL, Korbanic C, Hronakes ML et al. Mixed xenogeneic chimerism (mouse+rat to mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts. Transplantation 1994; 57: 592-8.
161. 161 Sablinski T, Gianello PR, Bailin M, Bergen KS, Emery DW, Fishman JA et al. Pig to monkey bone marrow and kidney xenotransplantation. Surgery 1997; 121: 381-91.
162. 162 Yang Y-G, Sergio JJ, Swenson K, Glaser RM, Monroy R, Sykes M. Donor specific growth factors promote swine hematopoiesis in severe combined immune deficient mice. Xenotransplantation 1996; 3: 92-101.
163. 163 Bannerjee PT, Ierino FL, Kaynor GC, Giovini M, Hawley R, Rosa MD et al. Expression of swine MHC class II genes in a cynomologous monkey: retrovirus mediated gene therapy in a preclinical transplantation model. Xenotransplantation 1997; 4: 174.
164. 164 Calne RY, Watson CJE, Brons IG, Makisalo H, Metcalfe SM, Sriwatanawongsa V et al. Tolerance of porcine renal allografts induced by donor spleen cells and seven days' treatment with cyclosporine. Transplantation 1994; 57: 1433-5.
165. 165 Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339: 1579-82.
166. 166 Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127-52.
167. 167 Zeng YJ, Ricordi C, Tzakis A, Rilo HL, Carroll PB, Starzl TE et al. Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat-B10 mouse). Transplantation 1992; 53: 277-83.
168. 168 Miniats OP. Production of germ free animals. Part II. Farm animals. In: Coates ME, Gustafsson BE, eds. The Germ Free Animal in Biomedical Research. London: Laboratory Animals, 1984: 49.
169. 169 Chiche L, Adam R, Caillat-Zucman S, Castaing D, Bach JF, Bismuth H. Xenotransplantation: baboons as potential liver donors? Scientific and ethical issues. Transplantation 1993; 55: 1418-21.
170. 170 Michaels MG, Simmons RL. Xenotransplant associated zoonoses. Strategies for prevention. Transplantation 1994; 57: 1-7.
171. 171 Groth CG. Xenotransplantation. The viral issue. Lancet 1998; 352(Suppl 4): S26.
172. 172 Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997; 3: 282-6.
173. 173 Martin U, Kiessig V, Blusch JH, Haverich A, von der Helm K, Herden T et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 1998; 352: 692-4.
174. 174 Heneine W, Tibell A, Switzer M, Sandstrom P, Rosales GV, Mathews A et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998; 352: 695-9.
175. 175 Patience C, Patton GS, Takeuchi Y, Weiss RA, McClure MO, Rydberg L et al. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 1998; 352: 699-701.
176. 176 Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer WM et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 1999; 285: 1236-41.
177. 177 Martin U, Steinhoff G, Kiessig V, Chikobava M, Anssar M, Marschheuser T et al. Porcine endogenous retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo. Transpl Int 1998; 11: 247-51.
178. 178 UK Department of Health. Draft Report of the Infection Surveillance Steering Group of the UKXIRA. XXX: UK Department of Health, 1999.